Novità nel mondo di Medicina di Laboratorio
MicroRNA-221 and MicroRNA-222 in Common Human Cancers
A better understanding of the function of microRNAs in various types of cancers could have important implications for cancer treatment.
Laboratory Medicine
Laboratory Medicine
Categorie: Novità nel mondo di Medicina di Laboratorio
Next-Generation Sequencing and Clinical Oncology Workflow
Technological challenges limit successful integration of genomic data into the electronic health record. Solutions, such as ASCO CancerLinQ, are discussed here.
JCO Precision Oncology
JCO Precision Oncology
Categorie: Novità nel mondo di Medicina di Laboratorio
Mepolizumab for Severe Asthma With Chronic Rhinosinusitis
Mepolizumab may be an effective treatment option for patients with severe asthma and underlying eosinophilic chronic rhinosinusitis.
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Categorie: Novità nel mondo di Medicina di Laboratorio
Thrombolysis Effective for Treating Occluded Central Venous Catheters in Kids
Thrombolysis, particularly with alteplase, appears to be effective and likely safe for treating occluded central venous catheters in children with cancer, according to a meta-analysis.
Reuters Health Information
Reuters Health Information
Categorie: Novità nel mondo di Medicina di Laboratorio
Limited Tissue Biopsies and Hematolymphoid Neoplasms
This study examines the applicability of fine-needle aspiration/needle core biopsy for evaluating hematolymphoid lesions.
American Journal of Clinical Pathology
American Journal of Clinical Pathology
Categorie: Novità nel mondo di Medicina di Laboratorio
Squamous Cell Carcinoma Arising From an Epidermal Cyst
In this report, a patient presented with a rare malignant transformation of an epidermal cyst. How was this case successfully treated, and what was the outcome?
ePlasty, Open Access Journal of Plastic Surgery
ePlasty, Open Access Journal of Plastic Surgery
Categorie: Novità nel mondo di Medicina di Laboratorio
Seated Saline Infusion Test for Predicting PA Subtypes
Is the seated saline infusion test an accurate means of determining primary aldosteronism subtypes? How does it compare with other tests?
Clinical Endocrinology
Clinical Endocrinology
Categorie: Novità nel mondo di Medicina di Laboratorio
Canagliflozin Helps Heart, Kidneys in 'Well-Controlled' Diabetes
A subanalysis of CREDENCE suggests that SGLT2 inhibitor use should be based on clinical benefit, not solely glycemic control, say researchers. Another study hints that these drugs up EPO levels.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Women With Non-STEMI ACS Underrepresented, Undertreated
Previous research has shown women with NSTEACS have higher mortality than men. A new study found the opposite — but disturbingly, women received fewer therapies and interventions.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Physician-Lawmakers Shape Congress' 'Surprise-Billing' Fix
Congress is trying to pass a federal 'surprise billing' law by year end.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Flu Season Gets Bad Weeks Earlier Than Last Year, CDC Says
Influenza activity is widespread or regional in more than half the country weeks earlier than last year, according to the CDC.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
AHA Scientific Statement on Managing Elderly in Cardiac ICU
The statement highlighted the many comorbidities that geriatric patients in the cardiac intensive care unit may have, including frailty and cognitive impairment, and suggested management strategies.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Two More Alzheimer's Drug Candidates Fail
The BACE inhibitor lanabecestat and the antibiotic minocycline failed to slow cognitive decline in randomized controlled trials.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
In Follicular Lymphoma, Can MRD Predict Relapse or Define Cure?
In a first-of-its-kind study, patients with follicular lymphoma who were in remission were followed for minimal residual disease (MRD) status, which may guide treatment.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Myeloma Patients Over Age 70 Can Benefit From Auto-HC Transplant
"Age has no implication in terms of the antimyeloma effect of transplant," said one oncologist. Researchers called this largest study of auto-HCT in older adults with multiple myeloma.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Long-duration Vancomycin Linked to Lower Rates of C. Diff Recurrence in IBD
In patients with inflammatory bowel disease (IBD), a long course of oral vancomycin is associated with lower odds of Clostridioides difficile infection recurrence than a short course, a retrospective chart review reveals.
Reuters Health Information
Reuters Health Information
Categorie: Novità nel mondo di Medicina di Laboratorio
TWTW: Healing Honey, Restored Limb Function, Anti-Cancer Anthrax
Three medical stories that we didn't cover, explained.
Medscape
Medscape
Categorie: Novità nel mondo di Medicina di Laboratorio
FDA Investigating Metformin for Possible Carcinogen
The Food and Drug Administration has begun testing samples of metformin for NDMA. The fourth most-prescribed drug in the US, metformin is generally the first medication prescribed for type 2 diabetes.
WebMD Health News
WebMD Health News
Categorie: Novità nel mondo di Medicina di Laboratorio
FDA Clears Faster Diagnostic Test for MRSA
The cobas vivoDx MRSA test uses a new bacteriophage technology based on bioluminescence to detect MRSA from nasal swab samples in 5 hours or less compared with 24 to 48 hours for conventional cultures.
FDA Approvals
FDA Approvals
Categorie: Novità nel mondo di Medicina di Laboratorio
U.S. FDA Clears Israeli Startup Sight Diagnostics' Finger Prick Blood Test
Israeli startup Sight Diagnostics said on Wednesday the U.S. Food and Drug Administration had cleared its device that can process results for the most commonly needed blood test in about ten minutes.
Reuters Health Information
Reuters Health Information
Categorie: Novità nel mondo di Medicina di Laboratorio